Literature DB >> 26033727

Ultrashort Antimicrobial Peptides with Antiendotoxin Properties.

Ya-Han Chih1, Yen-Shan Lin1, Bak-Sau Yip2, Hsiu-Ju Wei1, Hung-Lun Chu1, Hui-Yuan Yu1, Hsi-Tsung Cheng1, Yu-Ting Chou3, Jya-Wei Cheng3.   

Abstract

Release of lipopolysaccharide (LPS) (endotoxin) from bacteria into the bloodstream may cause serious unwanted stimulation of the host immune system. Some but not all antimicrobial peptides can neutralize LPS-stimulated proinflammatory responses. Salt resistance and serum stability of short antimicrobial peptides can be boosted by adding β-naphthylalanine to their termini. Herein, significant antiendotoxin effects were observed in vitro and in vivo with the β-naphthylalanine end-tagged variants of the short antimicrobial peptides S1 and KWWK.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26033727      PMCID： PMC4505259          DOI： 10.1128/AAC.00519-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  37 in total

Review 1.  Amphipathic, alpha-helical antimicrobial peptides.

Authors:  A Tossi; L Sandri; A Giangaspero
Journal:  Biopolymers       Date:  2000       Impact factor: 2.505

Review 2.  Animal antimicrobial peptides: an overview.

Authors:  D Andreu; L Rivas
Journal:  Biopolymers       Date:  1998       Impact factor: 2.505

3.  Membrane and lipopolysaccharide interactions of C-terminal peptides from S1 peptidases.

Authors:  Shalini Singh; Gopinath Kasetty; Artur Schmidtchen; Martin Malmsten
Journal:  Biochim Biophys Acta       Date:  2012-04-02

Review 4.  Lipopolysaccharide neutralization by antimicrobial peptides: a gambit in the innate host defense strategy.

Authors:  David Pulido; M Victòria Nogués; Ester Boix; Marc Torrent
Journal:  J Innate Immun       Date:  2012-03-21       Impact factor: 7.349

Review 5.  Lipopolysaccharide (Endotoxin)-host defense antibacterial peptides interactions: role in bacterial resistance and prevention of sepsis.

Authors:  Yosef Rosenfeld; Yechiel Shai
Journal:  Biochim Biophys Acta       Date:  2006-06-02

6.  Boosting salt resistance of short antimicrobial peptides.

Authors:  Hung-Lun Chu; Hui-Yuan Yu; Bak-Sau Yip; Ya-Han Chih; Chong-Wen Liang; Hsi-Tsung Cheng; Jya-Wei Cheng
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

7.  Parameters involved in antimicrobial and endotoxin detoxification activities of antimicrobial peptides.

Authors:  Yosef Rosenfeld; Hans-Georg Sahl; Yechiel Shai
Journal:  Biochemistry       Date:  2008-05-23       Impact factor: 3.162

8.  The central kink region of fowlicidin-2, an alpha-helical host defense peptide, is critically involved in bacterial killing and endotoxin neutralization.

Authors:  Yanjing Xiao; Alvaro I Herrera; Yugendar R Bommineni; Jose L Soulages; Om Prakash; Guolong Zhang
Journal:  J Innate Immun       Date:  2008-11-14       Impact factor: 7.349

Review 9.  Defensins: antifungal lessons from eukaryotes.

Authors:  Patrícia M Silva; Sónia Gonçalves; Nuno C Santos
Journal:  Front Microbiol       Date:  2014-03-20       Impact factor: 5.640

10.  The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria.

Authors:  Lorraine A Draper; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  BMC Microbiol       Date:  2013-09-26       Impact factor: 3.605
View more
  9 in total

1.  High Level Expression and Purification of Cecropin-like Antimicrobial Peptides in Escherichia coli.

Authors:  Chih-Lung Wu; Ya-Han Chih; Hsin-Ying Hsieh; Kuang-Li Peng; Yi-Zong Lee; Bak-Sau Yip; Shih-Che Sue; Jya-Wei Cheng
Journal:  Biomedicines       Date:  2022-06-08

2.  Antimicrobial activity and stability of the D-amino acid substituted derivatives of antimicrobial peptide polybia-MPI.

Authors:  Yanyan Zhao; Min Zhang; Shuai Qiu; Jiayi Wang; Jinxiu Peng; Ping Zhao; Ranran Zhu; Hailin Wang; Yuan Li; Kairong Wang; Wenjin Yan; Rui Wang
Journal:  AMB Express       Date:  2016-11-29       Impact factor: 3.298

3.  Antimicrobial Peptides Display Strong Synergy with Vancomycin Against Vancomycin-Resistant E. faecium, S. aureus, and Wild-Type E. coli.

Authors:  Chih-Lung Wu; Ju-Yun Hsueh; Bak-Sau Yip; Ya-Han Chih; Kuang-Li Peng; Jya-Wei Cheng
Journal:  Int J Mol Sci       Date:  2020-06-27       Impact factor: 5.923

Review 4.  Recent Advances in Anti-virulence Therapeutic Strategies With a Focus on Dismantling Bacterial Membrane Microdomains, Toxin Neutralization, Quorum-Sensing Interference and Biofilm Inhibition.

Authors:  Osmel Fleitas Martínez; Marlon Henrique Cardoso; Suzana Meira Ribeiro; Octavio Luiz Franco
Journal:  Front Cell Infect Microbiol       Date:  2019-04-02       Impact factor: 5.293

5.  Blood Compatibility-An Important but Often Forgotten Aspect of the Characterization of Antimicrobial Peptides for Clinical Application.

Authors:  Stephan Harm; Karl Lohner; Ute Fichtinger; Claudia Schildböck; Jennifer Zottl; Jens Hartmann
Journal:  Int J Mol Sci       Date:  2019-10-31       Impact factor: 5.923

6.  Interactive association of lipopolysaccharide and free fatty acid with the prevalence of type 2 diabetes: A community-based cross-sectional study.

Authors:  Xiuji Huang; Dan Yan; Mingtong Xu; Feng Li; Meng Ren; Jin Zhang; Muchao Wu
Journal:  J Diabetes Investig       Date:  2019-05-03       Impact factor: 4.232

7.  Antimicrobial Peptides with Enhanced Salt Resistance and Antiendotoxin Properties.

Authors:  Hung-Lun Chu; Ya-Han Chih; Kuang-Li Peng; Chih-Lung Wu; Hui-Yuan Yu; Doris Cheng; Yu-Ting Chou; Jya-Wei Cheng
Journal:  Int J Mol Sci       Date:  2020-09-16       Impact factor: 5.923

8.  A Novel Antimicrobial Peptide Derived from Bony Fish IFN1 Exerts Potent Antimicrobial and Anti-Inflammatory Activity in Mammals.

Authors:  Xun Xiao; Hao Lu; Wentao Zhu; Yanqi Zhang; Xingchen Huo; Chunrong Yang; Shaobo Xiao; Yongan Zhang; Jianguo Su
Journal:  Microbiol Spectr       Date:  2022-03-15

Review 9.  Synergy by Perturbing the Gram-Negative Outer Membrane: Opening the Door for Gram-Positive Specific Antibiotics.

Authors:  Charlotte M J Wesseling; Nathaniel I Martin
Journal:  ACS Infect Dis       Date:  2022-08-10       Impact factor: 5.578
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.